Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Zynerba Pharma CS (ZYNE)

22.02 -0.08 (-0.36%)

2/24/2017  4:00pm

Open:

22.48

Pre. Close:

22.10

High:

23.50

Low:

21.86

Volume:

871,217

Market Cap:

219.17M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

24.15 - 24.56

24.56 - 25.05

Low:

20.54 - 20.91

20.91 - 21.36

Close:

21.31 - 22.12

22.12 - 23.1

Technical analysis  (as of: 2017-02-24 4:39:54 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 27.74     One year: 32.40

Support:

Support1: 19.02    Support2: 16.09

Resistance:

Resistance1: 23.75    Resistance2: 27.74

Pivot:

20.78

Moving Averages:

MA(5): 21.73     MA(20): 19.96

MA(100): 15.68     MA(250): 11.69

MACD:

MACD(12,26): 1.18     Signal(12,26,9): 1.07

%K %D:

%K(14,3): 71.49     %D(3): 69.85

RSI:

RSI(14): 63.88

52-Week:

High: 23.75  Low: 5.69  Change(%): 267.0

Average Vol(K):

3-Month: 401  10-Days 573

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ZYNE has closed below upper band by 31.3%. Bollinger Bands are 57.1% wider than normal. The large width of the bands suggest high volatility as compared to ZYNE's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue.

Headline News

Thu, 19 Jan 2017 16:41:15 GMT
Why Zynerba Pharmaceuticals Inc. Is Tanking Today

Fri, 03 Jul 2015 16:14:29 GMT
Zynerba Pharmaceuticals Inc.

Fri, 31 Jul 2015 23:04:27 GMT
News Zynerba Pharmaceuticals Inc.ZYNE

Mon, 12 Dec 2016 15:39:34 GMT
Best Stocks for 2017: Zynerba Pharmaceuticals Inc (ZYNE) Is a Perfect Prescription

Fri, 24 Feb 2017 13:30:00 GMT
Zynerba Pharmaceuticals Inc (ZYNE) is Initiated by Maxim Group to “Buy”

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

12.79

Shares Float (M)

7.13

% Held by Insiders

% Held by Institutions

Shares Short (K)

1730

Shares Short Prior Month (K)

1640

Stock Financials

EPS

-2.480

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

3.210

PEG Ratio

Profit Margin

Operating Margin

-38813.06

Return on Assets (ttm)

-32.9

Return on Equity (ttm)

-58.3

Qtrly Rev. Growth

Gross Profit (p.s.)

0.022

Sales Per Share

0.004

EBITDA (p.s.)

-1.710

Qtrly Earnings Growth

Operating Cash Flow (M)

-18.13

Levered Free Cash Flow (M)

-10.08

FoxReading.com

Valuation

P/E

-8.88

P/E Growth Ratio

P/BV

6.86

P/S

4982.94

P/CF

-15.53

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.